contacts Sign In
image
author Image

Moderna/Merck begins late-stage study of skin cancer vaccine combination

  • Home
  • Healthcare
  • Moderna/Merck begins late-stage study of skin cancer vaccine combination
Data from a mid-stage study had shown that the combination cut the risk of recurrence or death of melanoma, the most deadly form of skin cancer, by 44per cent when compared with Keytruda alone.